Kyle Seamon

6PUBLICATIONS
133CO-AUTHORS
Molecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2026
Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer.

|Jun 22, 2026
Targeting KRAS Codon 13 Mutations Using Direct Combination Approaches in Non-Small Cell Lung Cancer.

|Jun 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-type RAS Isoforms in Codon 13 RAS-Mutant Cancers.

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.

Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato

|Aug 17, 2023
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS.

Christopher J Schulze, Kyle J Seamon, Yulei Zhao

Pageof 1

Frequent Collaborators

5 joint publications

Jacqueline A M Smith

5 joint publications

Mallika Singh

4 joint publications

Jingjing Jiang

4 joint publications

Matthew Holderfield